Qinghai Spring(SH:600381)2022-04-29 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥75,221,543.33, representing a significant increase of 270.40% compared to the same period last year[4] - The net profit attributable to shareholders of the listed company was -¥23,568,451.50, with a basic and diluted earnings per share of -¥0.0401[4] - The net loss for Q1 2022 was 23,568,451.50 RMB, compared to a net loss of 8,834,120.72 RMB in Q1 2021, reflecting a deterioration in profitability[19] - The total profit for Q1 2022 was -18,717,152.75 RMB, compared to -5,736,161.38 RMB in Q1 2021, indicating a significant increase in losses[27] - The basic and diluted earnings per share for Q1 2022 were both -0.0401 RMB, compared to -0.015 RMB in Q1 2021, indicating a worsening in earnings per share[20] Cash Flow - The net cash flow from operating activities was -¥21,460,326.43, indicating a negative cash flow situation[4] - The cash inflow from operating activities in Q1 2022 was 96,285,109.72 RMB, compared to 21,285,735.68 RMB in Q1 2021, showing an increase of approximately 353.5%[21] - The net cash flow from operating activities was -26,776,631.71 RMB in Q1 2022, slightly worse than -26,186,429.58 RMB in Q1 2021[29] - The net cash flow from investing activities was positive CNY 34,298,003.68, compared to negative CNY 71,063,637.39 in the same period last year[22] - The company reported cash inflows from investment activities of 124,607,473.33 RMB in Q1 2022, down from 315,631,864.35 RMB in Q1 2021[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,827,564,968.79, a decrease of 1.11% from the end of the previous year[5] - The total liabilities as of Q1 2022 amounted to 30,652,919.38 RMB, an increase from 27,640,371.20 RMB in the previous year, which is an increase of about 11.0%[17] - The total assets as of March 31, 2022, were CNY 1,698,549,591.61, a decrease from CNY 1,718,647,399.86 at the end of 2021[25] - The total liabilities as of March 31, 2022, were CNY 57,576,644.38, down from CNY 58,957,299.88 at the end of 2021[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 54,290[10] - The company reported a total of 199,115,194 shares held by Tibet Rong'en Technology Co., Ltd., representing 33.92% of total shares[12] - The top ten shareholders include significant holdings from individuals and entities, with the largest being Tibet Rong'en Technology Co., Ltd.[12] Revenue Sources - The increase in operating revenue was primarily driven by a substantial rise in sales from the liquor business, which generated ¥52,969,500, an increase of 1101.59%, and the traditional Chinese medicine sales, which brought in ¥11,631,200, an increase of 159.47%[8] - Total operating costs for Q1 2022 were 99,888,883.12 RMB, up from 37,257,278.46 RMB in Q1 2021, indicating an increase of about 168.5%[18] Research and Development - Research and development expenses for Q1 2022 were 1,416,075.33 RMB, compared to 1,738,289.21 RMB in Q1 2021, reflecting a decrease of about 18.5%[18] - The company has not disclosed any new product developments or market expansion strategies in this report[1] - The company has not disclosed any significant new product developments or market expansion strategies during this reporting period[13] Other Financial Metrics - Non-recurring gains and losses totaled ¥836,756.69 for the period, after accounting for tax effects[8] - The company incurred increased marketing expenses of approximately ¥36 million compared to the same period last year, contributing to the larger net loss[8] - The company did not report any cash inflows from financing activities in Q1 2022[29] - The company has not adopted the new accounting standards for the current year[30] - The board of directors announced the Q1 2022 results on April 29, 2022[31]